These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 25997494)
21. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells. Kim JR; Kim CH Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474 [TBL] [Abstract][Full Text] [Related]
22. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression. Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677 [TBL] [Abstract][Full Text] [Related]
23. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
24. Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases. Sun CY; Hu Y; Wang HF; He WJ; Wang YD; Wu T Chin Med J (Engl); 2006 Apr; 119(7):589-95. PubMed ID: 16620701 [TBL] [Abstract][Full Text] [Related]
25. Expression and activation of proteases in co-cultures. Paduch R; Kandefer-Szerszeń M Exp Toxicol Pathol; 2011 Jan; 63(1-2):79-87. PubMed ID: 19836935 [TBL] [Abstract][Full Text] [Related]
26. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell. Sakaida I; Hironaka K; Kimura T; Terai S; Yamasaki T; Okita K Life Sci; 2004 Mar; 74(18):2251-63. PubMed ID: 14987950 [TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302 [TBL] [Abstract][Full Text] [Related]
28. Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells. Fu OY; Hou MF; Yang SF; Huang SC; Lee WY Anticancer Res; 2009 Aug; 29(8):3131-8. PubMed ID: 19661326 [TBL] [Abstract][Full Text] [Related]
29. TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. Ellenrieder V; Hendler SF; Ruhland C; Boeck W; Adler G; Gress TM Int J Cancer; 2001 Jul; 93(2):204-11. PubMed ID: 11410867 [TBL] [Abstract][Full Text] [Related]
30. Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. Matsuyama Y; Takao S; Aikou T J Surg Oncol; 2002 Jun; 80(2):105-10. PubMed ID: 12173379 [TBL] [Abstract][Full Text] [Related]
31. [The role of matrixmetalloproteinases in the tumor growth and metastasis]. Velinov N; Poptodorov G; Gabrovski N; Gabrovski S Khirurgiia (Sofiia); 2010; (1):44-9. PubMed ID: 21972705 [TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Baker EA; Bergin FG; Leaper DJ Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431 [TBL] [Abstract][Full Text] [Related]
33. Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA. Yodkeeree S; Garbisa S; Limtrakul P Acta Pharmacol Sin; 2008 Jul; 29(7):853-60. PubMed ID: 18565284 [TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats. Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079 [TBL] [Abstract][Full Text] [Related]
36. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells. Festuccia C; Angelucci A; Gravina GL; Villanova I; Teti A; Albini A; Bologna M Int J Cancer; 2000 Feb; 85(3):407-15. PubMed ID: 10652434 [TBL] [Abstract][Full Text] [Related]
37. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue. Matsunaga Y; Koda M; Murawaki Y Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313 [TBL] [Abstract][Full Text] [Related]
38. Protein kinase C-mediated regulation of matrix metalloproteinase and tissue inhibitor of metalloproteinase production in a human retinal müller cells. Miyata Y; Kase M; Sugita Y; Shimada A; Nagase T; Katsura Y; Kosano H Curr Eye Res; 2012 Sep; 37(9):842-9. PubMed ID: 22667460 [TBL] [Abstract][Full Text] [Related]
39. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system. Smit JW; van der Pluijm G; Romijn HA; Löwik CW; Morreau H; Goslings BM Thyroid; 1999 Sep; 9(9):913-9. PubMed ID: 10524570 [TBL] [Abstract][Full Text] [Related]
40. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas. Görögh T; Beier UH; Bäumken J; Meyer JE; Hoffmann M; Gottschlich S; Maune S Head Neck; 2006 Jan; 28(1):31-9. PubMed ID: 16265652 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]